A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With Rheumatoid Arthritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 May 2017
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors TSH Biopharm
- 26 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 12 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016.
- 05 Feb 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.